Literature DB >> 19002816

Transgenic rabbits expressing human lipoprotein lipase.

M Araki1, J Fan, M Challah, A Bensadoun, N Yamada, K Honda, T Watanabe.   

Abstract

To study the functions of lipoprotein lipase (LPL) in lipid and lipoprotein metabolism and the relationship between LPL and atherosclerosis, we generated transgenic rabbits expressing the human LPL gene. A total of 4045 Japanese whiterabbit embryos were microinjected with a 3.8-kb SalI/HindIII fragment containing the chicken beta-actin promoter, human LPL cDNA and rabbit beta-globin with poly (A) signals, and then transplanted into 116 recipient rabbits. Of the 166 pups born, six pups were transgenic as confirmed by Southern blot analysis. ANorthern blot analysis revealed that human LPL was expressed by a number of tissues including the heart, kidney, adrenal gland and intestine. One transgenic rabbit showed up to 3-foldincreased LPL activity in post-heparin plasma compared to thatin nontransgenic rabbits. Human LPL expression in various tissues of transgenic rabbits was further elucidated by in situ hybridization and immunostaining. Since rabbits are superior to mice as a model of atherosclerosis, this transgenicrabbit model should provide a valuable tool for the study of LPL in lipid metabolism and atherosclerosis.

Entities:  

Year:  2000        PMID: 19002816      PMCID: PMC3466728          DOI: 10.1023/A:1008115429679

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  27 in total

Review 1.  Transgenic rabbit models for the study of atherosclerosis.

Authors:  J M Taylor; J Fan
Journal:  Front Biosci       Date:  1997-06-15

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.

Authors:  J Fan; Z S Ji; Y Huang; H de Silva; D Sanan; R W Mahley; T L Innerarity; J M Taylor
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Purification and characterization of lipoprotein lipase from pig adipose tissue.

Authors:  A Bensadoun; C Ehnholm; D Steinberg; W V Brown
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

5.  Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.

Authors:  K D O'Brien; D Gordon; S Deeb; M Ferguson; A Chait
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.

Authors:  S Ylä-Herttuala; B A Lipton; M E Rosenfeld; I J Goldberg; D Steinberg; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Transgenic rabbits expressing human apolipoprotein A-I in the liver.

Authors:  N Duverger; C Viglietta; L Berthou; F Emmanuel; A Tailleux; L Parmentier-Nihoul; B Laine; C Fievet; G Castro; J C Fruchart; L M Houbebine; P Denèfie
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-12       Impact factor: 8.311

8.  Lipoprotein lipase: cellular origin and functional distribution.

Authors:  L Camps; M Reina; M Llobera; S Vilaró; T Olivecrona
Journal:  Am J Physiol       Date:  1990-04

9.  Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta.

Authors:  L Mattsson; H Johansson; M Ottosson; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.

Authors:  S Yamanaka; M E Balestra; L D Ferrell; J Fan; K S Arnold; S Taylor; J M Taylor; T L Innerarity
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  3 in total

Review 1.  The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.

Authors:  Zs Bosze; L Hiripi; J W Carnwath; H Niemann
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

Review 2.  Transgenic rabbit models for studying human cardiovascular diseases.

Authors:  Xuwen Peng
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

3.  CRISPR/Cas9 mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia.

Authors:  Yi Yang; Xiangjin Kang; Shiqi Hu; Bangzhu Chen; Yingjun Xie; Bing Song; Quanjun Zhang; Han Wu; Zhanhui Ou; Yexing Xian; Yong Fan; Xiaoping Li; Liangxue Lai; Xiaofang Sun
Journal:  J Biol Chem       Date:  2021-02-24       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.